Accelmed Ventures II is aiming to create successful, high value medical device and digital health companies by focusing on strong teams, large markets and novel ideas.
Led by Dr. Irit Yaniv and Amir Blatt, with an experienced supporting team, proven track record of success and global operations, Accelmed Ventures II positions itself as a leading HealthTech venture fund.
Accelmed Ventures II invests in major chronic disease areas such as neurodegenerative, metabolic and cardiovascular diseases to develop and cultivate innovative solutions.
Accelmed Ventures II is seeking companies with a proven business model and exceptional entrepreneurs in the field of digital health.
Investment strategies include: